ImaginAb teams with Duke-NUS

Imaging agent developer ImaginAb has partnered with Duke-NUS Graduate Medical School Singapore to establish a laboratory to develop new in vivo molecular imaging agents.

Under the terms of the agreement, ImaginAb and Duke-NUS will establish protein engineering and molecular imaging capabilities designed to interface with Duke-NUS' research programs in cancer and stem cell biology, cardiovascular and metabolic diseases, neurobiology, and immunology, ImaginAb said.

The new facilities will also support ImaginAb's R&D activities.

Page 1 of 435
Next Page